JP2014532168A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532168A5
JP2014532168A5 JP2014530734A JP2014530734A JP2014532168A5 JP 2014532168 A5 JP2014532168 A5 JP 2014532168A5 JP 2014530734 A JP2014530734 A JP 2014530734A JP 2014530734 A JP2014530734 A JP 2014530734A JP 2014532168 A5 JP2014532168 A5 JP 2014532168A5
Authority
JP
Japan
Prior art keywords
biomarkers
beta cell
level
acid
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014530734A
Other languages
English (en)
Japanese (ja)
Other versions
JP6158186B2 (ja
JP2014532168A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/054640 external-priority patent/WO2013039898A1/en
Publication of JP2014532168A publication Critical patent/JP2014532168A/ja
Publication of JP2014532168A5 publication Critical patent/JP2014532168A5/ja
Application granted granted Critical
Publication of JP6158186B2 publication Critical patent/JP6158186B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014530734A 2011-09-14 2012-09-11 インスリン抵抗性に関連するバイオマーカーおよびそれを使用する方法 Active JP6158186B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161534679P 2011-09-14 2011-09-14
US61/534,679 2011-09-14
PCT/US2012/054640 WO2013039898A1 (en) 2011-09-14 2012-09-11 Biomarkers related to insulin resistance and methods using the same

Publications (3)

Publication Number Publication Date
JP2014532168A JP2014532168A (ja) 2014-12-04
JP2014532168A5 true JP2014532168A5 (https=) 2015-10-08
JP6158186B2 JP6158186B2 (ja) 2017-07-05

Family

ID=47883643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014530734A Active JP6158186B2 (ja) 2011-09-14 2012-09-11 インスリン抵抗性に関連するバイオマーカーおよびそれを使用する方法

Country Status (4)

Country Link
US (1) US10302663B2 (https=)
EP (1) EP2756095A4 (https=)
JP (1) JP6158186B2 (https=)
WO (1) WO2013039898A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3026266B1 (ja) 1999-03-26 2000-03-27 光昭 佐々木 懸垂蒲鉾型鉗子式頸椎牽引具
US20140324460A1 (en) * 2012-09-26 2014-10-30 Health Diagnostic Laboratory, Inc. Method for determining and managing total cardiodiabetes risk
EP2943790A1 (en) * 2013-01-11 2015-11-18 Health Diagnostic Laboratory, Inc. Method of detection of clinically significant post-prandial hyperglycemia in normoglycemic patients
JP6773951B2 (ja) * 2014-05-30 2020-10-21 学校法人東京医科大学 唾液試料の調製方法
US10487314B2 (en) 2014-06-26 2019-11-26 The Trustees Of Columbia University In The City Of New York Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
CA2976052C (en) * 2015-02-06 2023-03-21 Metabolon, Inc. Diagnostic methods, therapeutic agents and uses thereof
US10732173B2 (en) 2015-09-15 2020-08-04 The Trustees Of Columbia University In The City Of New York Use of aldehyde dehydrogenase as biomarker for beta-cell dysfunction and loss
CN106979982B (zh) * 2016-01-19 2021-01-05 上海市第六人民医院 一种用于糖尿病风险预测、治疗评价的方法及试剂盒
US20210223270A1 (en) * 2018-12-27 2021-07-22 Public University Corporation Nara Medical University Method for diagnosing interstitial cystitis
IL321485A (en) * 2022-12-14 2025-08-01 Luminous Mind Inc Treatment of psychological symptoms affecting other medical conditions (PFAOMC)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764989B1 (fr) 1997-06-20 1999-08-27 Pasteur Sanofi Diagnostics Procede de dosage du c-peptide
US7700555B2 (en) * 2004-07-15 2010-04-20 Joslin Diabetes Center, Inc. Methods of treating diabetes
JP4522222B2 (ja) 2004-10-22 2010-08-11 扶桑薬品工業株式会社 血中脂肪酸濃度測定による心疾患の早期診断方法
CN101802620A (zh) 2007-02-22 2010-08-11 特提斯生物科学公司 糖尿病状况的代谢标志物及其使用方法
CA2690541A1 (en) 2007-07-17 2009-01-29 Metabolon, Inc. Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
US20110311650A1 (en) 2008-07-07 2011-12-22 Thomas Wang Multiplexed biomarkers of insulin resistance
EP2414535A4 (en) * 2009-03-31 2012-12-26 Metabolon Inc BIOMARKERS RELATED TO INSULIN RESISTANCE AND METHOD OF USE THEREOF

Similar Documents

Publication Publication Date Title
JP2014532168A5 (https=)
Fang et al. World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation
JP2012522989A5 (https=)
JP2015064362A5 (https=)
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
JP2009538607A5 (https=)
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
EA201170332A1 (ru) Способ идентификации факторов риска заболеваний
PE20141450A1 (es) Ensayo de lisiloxidasa-homologo 2 y metodos de uso del mismo
WO2015048336A3 (en) Markers for amyotrophic lateral sclerosis (als) and presymptomatic alzhimer's disease (psad)
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
WO2014179424A3 (en) Lipidomic biomarkers
WO2016117969A3 (ko) 병변 영상 분석을 통한 광 치료 장치，이에 이용되는 병변 영상 분석에 의한 병변 위치 검출방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체
JP2017505897A5 (https=)
WO2012006056A3 (en) Ccr6 as a biomarker of alzheimer's disease
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
JP2016526167A5 (https=)
EP2044212A4 (en) METHOD FOR IDENTIFYING PATIENTS WITH INCREASED RISK FOR AN UNWANTED HEART CIRCUIT EVENT
MX2014011045A (es) Metodo para seleccionar o identificar un sujeto para la terapia antagonista vib.
HK1258207A1 (zh) 基於鉴别和改善肝功能障碍来诊断和治疗帕金森病
EP2711708A1 (en) Determination of tryptophan metabolites for assessing liver cell function
MX2014008306A (es) Medios y metodos para tratar o diagnosticar canceres positivos a idh1 r132h mutante.
Bhatt et al. Clinical laboratory experience with noninvasive prenatal testing: update on clinically relevant metrics
JP2014208601A5 (https=)
CN102380107A (zh) 一种检测病人对药物是否过敏的方法